Wells Fargo Remains a Buy on Dexcom (DXCM)
In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of ...
DexCom (NASDAQ:DXCM) Given New $99.00 Price Target at Canaccord Genuity Group
DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $89.00 to $99.00 in a research report issued to clients and investors on Monday, ...
DexCom: Brighter 2025 From Stelo Ramp
DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...
drugdeliverybusiness1 天
Tandem makes t:slim X2 insulin pump available with Dexcom G7 in Canada
Tandem Diabetes Care announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with ...
Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...
Zacks.com on MSN5 天
Reasons to Retain TNDM Stock in Your Portfolio for Now
Tandem Diabetes Care, Inc.’s TNDM third-quarter growth is backed by its impressive range of new products. The robust ...